中国医药
中國醫藥
중국의약
CHINA MEDICINE
2014年
4期
464-467
,共4页
王印华%王宝华%唐明贵%柴海霞%浦践一
王印華%王寶華%唐明貴%柴海霞%浦踐一
왕인화%왕보화%당명귀%시해하%포천일
心肌损伤%卡巴胆碱%急诊创伤%肠屏障功能障碍
心肌損傷%卡巴膽堿%急診創傷%腸屏障功能障礙
심기손상%잡파담감%급진창상%장병장공능장애
Myocardium injury%Carbachol%Emergency trauma%Intestinal barrier dysfunction
目的 探讨卡巴胆碱对急诊创伤后肠屏障功能障碍患者心肌的保护作用.方法 选择70例急诊创伤后肠屏障功能障碍综合征的患者完全随机分为卡巴胆碱组(37例)和莫沙必利组(33例),监测患者第1、7天外周血二胺氧化酶活性、嗜中性多形核粒细胞CD11b+/CD18的表达率、左心室射血分数及肌酸激酶同工酶峰值,观察临床疗效.结果 治疗后7d,卡巴胆碱组有效26例(70.3%),死亡7例(18.9%);莫沙必利组有效15例(45.5%),死亡13例(39.4%).卡巴胆碱组有效率优于莫沙必利组,差异有统计学意义(x2=4.43,P< 0.05).卡巴胆碱组治疗第1天血二胺氧化酶、CD11b+和CD18分别为(4.8±0.5)kU/L、(30.6±3.6)%、(75.8±3.6)%,第7天分别为(3.2±0.5) kU/L、(14.9±2.2)%、(53.7±2.4)%;莫沙必利组治疗第1天血二胺氧化酶、CD11b+和CD18分别为(4.7±0.3)kU/L、(31.1±2.9)%、(74.6±2.7)%,第7天分别为(3.9±0.5)kU/L、(28.9±1.6)%、(72.5±4.1)%,治疗第7天卡巴胆碱组患者血二胺氧化酶水平、嗜中性多形核粒细胞CD11b及CD18阳性表达率均低于入组第1天及莫沙必利组,差异均有统计学意义(均P<0.05).2组患者入组时肌酸激酶同工酶差异无统计学意义,而卡巴胆碱组肌酸激酶同工酶峰值明显低于莫沙必利组[(60±19) U/L比(79±18) U/L],差异有统计学意义(P<0.05);2组患者入组时左心室射血分数差异无统计学意义,卡巴胆碱组左心室射血分数峰值高于莫沙必利组[(60±7)%比(55±7)%],差异有统计学意义(P<0.05).结论 卡巴胆碱通过降低急诊创伤后肠屏障功能障碍患者肠道缺血再灌注损伤、减少活性炎症介质释放、促进肠蠕动,从而减轻心肌损伤,保护远隔脏器-心脏的功能.
目的 探討卡巴膽堿對急診創傷後腸屏障功能障礙患者心肌的保護作用.方法 選擇70例急診創傷後腸屏障功能障礙綜閤徵的患者完全隨機分為卡巴膽堿組(37例)和莫沙必利組(33例),鑑測患者第1、7天外週血二胺氧化酶活性、嗜中性多形覈粒細胞CD11b+/CD18的錶達率、左心室射血分數及肌痠激酶同工酶峰值,觀察臨床療效.結果 治療後7d,卡巴膽堿組有效26例(70.3%),死亡7例(18.9%);莫沙必利組有效15例(45.5%),死亡13例(39.4%).卡巴膽堿組有效率優于莫沙必利組,差異有統計學意義(x2=4.43,P< 0.05).卡巴膽堿組治療第1天血二胺氧化酶、CD11b+和CD18分彆為(4.8±0.5)kU/L、(30.6±3.6)%、(75.8±3.6)%,第7天分彆為(3.2±0.5) kU/L、(14.9±2.2)%、(53.7±2.4)%;莫沙必利組治療第1天血二胺氧化酶、CD11b+和CD18分彆為(4.7±0.3)kU/L、(31.1±2.9)%、(74.6±2.7)%,第7天分彆為(3.9±0.5)kU/L、(28.9±1.6)%、(72.5±4.1)%,治療第7天卡巴膽堿組患者血二胺氧化酶水平、嗜中性多形覈粒細胞CD11b及CD18暘性錶達率均低于入組第1天及莫沙必利組,差異均有統計學意義(均P<0.05).2組患者入組時肌痠激酶同工酶差異無統計學意義,而卡巴膽堿組肌痠激酶同工酶峰值明顯低于莫沙必利組[(60±19) U/L比(79±18) U/L],差異有統計學意義(P<0.05);2組患者入組時左心室射血分數差異無統計學意義,卡巴膽堿組左心室射血分數峰值高于莫沙必利組[(60±7)%比(55±7)%],差異有統計學意義(P<0.05).結論 卡巴膽堿通過降低急診創傷後腸屏障功能障礙患者腸道缺血再灌註損傷、減少活性炎癥介質釋放、促進腸蠕動,從而減輕心肌損傷,保護遠隔髒器-心髒的功能.
목적 탐토잡파담감대급진창상후장병장공능장애환자심기적보호작용.방법 선택70례급진창상후장병장공능장애종합정적환자완전수궤분위잡파담감조(37례)화막사필리조(33례),감측환자제1、7천외주혈이알양화매활성、기중성다형핵립세포CD11b+/CD18적표체솔、좌심실사혈분수급기산격매동공매봉치,관찰림상료효.결과 치료후7d,잡파담감조유효26례(70.3%),사망7례(18.9%);막사필리조유효15례(45.5%),사망13례(39.4%).잡파담감조유효솔우우막사필리조,차이유통계학의의(x2=4.43,P< 0.05).잡파담감조치료제1천혈이알양화매、CD11b+화CD18분별위(4.8±0.5)kU/L、(30.6±3.6)%、(75.8±3.6)%,제7천분별위(3.2±0.5) kU/L、(14.9±2.2)%、(53.7±2.4)%;막사필리조치료제1천혈이알양화매、CD11b+화CD18분별위(4.7±0.3)kU/L、(31.1±2.9)%、(74.6±2.7)%,제7천분별위(3.9±0.5)kU/L、(28.9±1.6)%、(72.5±4.1)%,치료제7천잡파담감조환자혈이알양화매수평、기중성다형핵립세포CD11b급CD18양성표체솔균저우입조제1천급막사필리조,차이균유통계학의의(균P<0.05).2조환자입조시기산격매동공매차이무통계학의의,이잡파담감조기산격매동공매봉치명현저우막사필리조[(60±19) U/L비(79±18) U/L],차이유통계학의의(P<0.05);2조환자입조시좌심실사혈분수차이무통계학의의,잡파담감조좌심실사혈분수봉치고우막사필리조[(60±7)%비(55±7)%],차이유통계학의의(P<0.05).결론 잡파담감통과강저급진창상후장병장공능장애환자장도결혈재관주손상、감소활성염증개질석방、촉진장연동,종이감경심기손상,보호원격장기-심장적공능.
Objective To explore protection of carbachol for myocardium in patients with intestinal barrier dysfunction induced by emergency trauma.Methods Seventy patients after trauma with a definite diagnosis of multiple organ dysfunction syndrome in intensive care unit were included,were randomly divided into the carbachol group (n =37) and mosapride citrate group(n =33).Diamine oxidase activity,expressions of CD11b + and CD18 on polymor phonuclear meutrophilc(PMN) in peripheral blood and left ventricular ejection fraction(LVEF) were detected on the 1st and 7th day,as well as the peak contents of creatine kinase-MB (CK-MB).Clinical effects were observed.Results After treatment of 7 days,26 cases(70.3%) in carbachol group were effective in treatment,7 cases(18.9%)died,while 15 cases(45.5%) in mosapride citrate group were effective in treatment,13 cases(39.4%) died.Carbachol group showed a higher effective rate than the mosapride citrate group,thus the scores had statistical difference(x2 =4.43,P < 0.05).On the 1 st day,diamine oxidase,CD11b + and CD18 in carbachol group was(4.8 ± 0.5) kU/L,(30.6 ± 3.6) %,(75.8 ± 3.6) %,on 7th day was (3.2 ± 0.5) kU/L,(14.9 ± 2.2)%,(53.7 ± 2.4)%.On the 1 st day diamine oxidase,CD11b + and CD18 in mosapride citrate group was(4.7 ±0.3)kU/L,(31.1 ±2.9)%,(74.6 ±2.7)%,on 7th day was(3.9 ±0.5) kU/L,(28.9 ± 1.6)%,(72.5 ± 4.1)%.After treatment of 7 days,diamine oxidase,CD11b + and CD18 in carbachol group was lower than the inclusion spot and mosapride citrate group,thus the scores had statistical difference(P <0.05).CK-MB had no statistical difference at the moment of entering between the two groups.But in carbachol group,the peak contents of CK-MB was lower than that of mosapride citrate group[(60 ± 19)U/L vs (79 ± 18)U/L],scores had statistical difference(P < 0.05).Left ventricular ejection fraction had no statistical difference at the moment of entering the group between the two groups.But in carbachol group,the peak was higher than that of mosapride citrate group[(60-± 19) U/L vs (79 ± 18) U/L],thus the score had statistically difference (P < 0.05).Conclusions To the patients of intestinal barrier dysfunction induced by emergency trauma,by lessening the ischemic/reperfusion injury,inhibiting the production of inflammatory cytokines in vivo and promoting peristalsis of intestinal tract.Carbachol can loosen the myocardium injury and protect remote organ-heart function.